1 completed, 1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow James Felker: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Vaccine Trial for Low Grade Gliomas Experimental: HLA-A2 Restricted Glioma Antigen-Peptides with Poly-ICLC - Low Grade Glioma | Phase 2 | Recruiting | James Felker | 25 | 2015-01-01 | 2026-01-07 |
| Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod HLA-A2 restricted synthetic tumor antigen, Imiquimod, enzyme-linked immunosorbent assay - Ependymoma | Phase 1 | Terminated | James Felker | 23 | 2012-08-01 | 2026-02-05 |
| A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas HLA-A2 restricted glioma antigen peptides vaccine, Poly-ICLC - Newly Diagnosed Pediatric Pontine Glioma, Newly Diagnosed Pediatric High Grade Glioma | Phase 1 | Completed | James Felker | 60 | 2009-02-01 | 2024-12-06 |
Ependymoma (1)
poly ICLC (2) · Enzyme-Linked Immunosorbent Assay (1) · Flow Cytometry (1) · Imiquimod (1) · Immunohistochemistry (1)
United States (3)
R01CA174858 (1), R01CA187219 (1)